Clinical trial technology sits at the intersection of scientific rigour and operational urgency. Electronic Data Capture (EDC) systems, Clinical Trial Management Systems (CTMS), randomisation and trial supply management (RTSM) platforms, and patient-facing ePRO applications must be available continuously — not because of commercial SLAs, but because unavailability directly affects trial integrity, regulatory compliance, and, in some cases, patient safety.
A trial site coordinator who can't access the EDC to enter a serious adverse event (SAE) within the regulatory reporting window is not experiencing a technical inconvenience. They are at risk of a protocol deviation. A site that cannot randomise a patient because the RTSM is unavailable may lose that enrolment permanently. A patient who can't submit their symptom diary because the ePRO app is down generates a missing data point that clinical biostatisticians must account for in their analysis.
This guide covers the specific uptime requirements of clinical trial tech platforms, what to monitor across the trial operations stack, and how to configure Vigilmon to protect the data integrity and compliance posture that trials depend on.
Why Clinical Trial Platform Uptime Is a Regulatory and Scientific Obligation
SAE Reporting Has Hard Regulatory Deadlines
Serious Adverse Events must be reported to health authorities within defined windows — often 15 calendar days for non-fatal unexpected SAEs and 7 days for fatal or life-threatening events under ICH E2A guidelines. These clocks start from the moment a site becomes aware of the event. If the EDC is unavailable when a site attempts to enter the SAE, the regulatory clock is still running.
Clinical operations teams that discover an EDC outage only when a site calls to report they can't enter data are in a significantly worse position than those with a monitoring alert that fired within 60 seconds of the platform becoming unavailable.
Randomisation Failures Can Invalidate Trial Enrolments
The randomisation process assigns patients to treatment or placebo arms according to a pre-specified algorithm. When the RTSM platform is unavailable at the moment of randomisation, sites cannot proceed — and in many protocols, the randomisation window closes. A patient who was eligible and present but could not be randomised due to system unavailability may represent a lost enrolment that costs thousands of pounds and weeks of recruitment time to replace.
Vigilmon monitoring on the RTSM randomisation endpoint catches availability failures immediately, giving clinical operations and IT teams time to invoke contingency procedures before sites lose enrolment opportunities.
ePRO Missing Data Affects Biostatistical Analysis
Patient-Reported Outcome (PRO) data collected via electronic diary applications is primary endpoint data in many modern trials. Regulatory agencies expect a missing data rate below pre-specified thresholds — typically under 15–20% for primary endpoint windows. When the ePRO platform is unavailable during a patient's data entry window, that diary visit generates a missing data point.
A platform outage affecting 200 patients during a weekly diary window can materially affect the completeness of primary endpoint data — and in double-blind trials, the missing data mechanism must be formally accounted for in the statistical analysis plan.
What to Monitor in a Clinical Trial Tech Stack
1. EDC (Electronic Data Capture) Data Entry Endpoints
The EDC is the system of record for all clinical data. Site coordinators and investigators depend on it daily for data entry, query resolution, and source data verification. Monitor:
- Case Report Form (CRF) submission endpoints
- Data query generation and response endpoints
- Medical coding service endpoints (MedDRA, WHODrug)
- Audit trail and change log endpoints
Check intervals of 60 seconds are appropriate for production EDC systems. During active enrolment phases and close-out windows, consider alerting directly to clinical operations management for outages exceeding 10 minutes.
2. RTSM / IRT Randomisation and Drug Supply Endpoints
The randomisation and trial supply management system controls patient assignment and investigational product allocation. Monitor:
- Patient randomisation endpoints
- Drug kit assignment and dispensation endpoints
- Resupply trigger and depot management endpoints
- Visit scheduling and eligibility check endpoints
A randomisation endpoint failure should trigger immediate escalation — P1 severity — because every minute of unavailability during an active site visit is a potential lost enrolment.
3. ePRO / eCOA Patient-Facing Application
Electronic Patient-Reported Outcome and electronic Clinical Outcome Assessment applications are used by patients on personal devices. Monitor:
- Patient login and authentication endpoints
- Diary submission and data sync endpoints
- Reminder and notification delivery endpoints
- Visit compliance confirmation endpoints
Heartbeat monitoring on the nightly sync job that reconciles device-cached data with the central database catches the silent failure where submissions stop reaching the server even though the patient app appears to be working.
4. CTMS (Clinical Trial Management System)
The CTMS manages site relationships, monitoring visit scheduling, regulatory document tracking, and enrolment tracking. Monitor:
- Site and investigator management endpoints
- Regulatory document upload and approval endpoints
- Enrolment milestone and accrual tracking endpoints
- Monitoring visit scheduling and reporting endpoints
5. Safety Signal and Pharmacovigilance Integration
Clinical trial platforms integrate with pharmacovigilance (PV) systems to route SAE data for aggregate safety review. Monitor:
- SAE import and export endpoints between EDC and PV system
- Medical review workflow trigger endpoints
- Expedited reporting gateway endpoints
- Safety narrative generation service endpoints
A broken SAE integration that silently stops routing safety data to the PV system is one of the highest-risk silent failures in clinical trial tech — it is not discovered until a reconciliation exercise finds the discrepancy.
6. Regulatory Submission Gateway
Trial documents — protocols, amendments, consent forms, investigator brochures — flow through regulatory submission platforms to health authorities. Monitor:
- Document management system endpoints
- eSubmission gateway connectivity (eCTD, IDMP)
- Regulatory authority portal connectors
- Digital signature and approval workflow endpoints
7. SSL Certificates and Authentication Services
Clinical trial platforms handle highly sensitive patient data and require robust authentication — single sign-on (SSO), multi-factor authentication (MFA), and role-based access control. Monitor:
- SSL certificates on all production portals and APIs
- SSO and identity provider (IdP) endpoints
- MFA delivery service endpoints (email, SMS)
- Session management and token refresh endpoints
An expired SSL certificate on an EDC portal causes browser security warnings and effectively blocks site access — an outage that is entirely preventable with certificate monitoring.
Configuring Vigilmon for GCP-Compliant Monitoring
Clinical trial platforms operate under Good Clinical Practice (GCP) requirements, including audit trails, validation, and change control. Vigilmon's monitoring infrastructure operates entirely outside your validated clinical systems — it makes outbound HTTP requests to your production endpoints and records response status, latency, and timestamp. This is a non-invasive monitoring pattern that does not affect your validated environment.
For GCP documentation purposes, Vigilmon check results provide timestamped availability records that can be cited in deviation investigations if an outage is identified as the root cause of a protocol deviation.
Vigilmon Setup for Clinical Trial Tech Teams
Step 1: Identify High-Impact Endpoints by Clinical Risk
Prioritise endpoints by their clinical consequence if unavailable:
Immediate P1 — patient safety and enrolment impact:
- RTSM randomisation endpoint
- EDC SAE submission endpoint
- ePRO diary submission endpoint
High priority — protocol and compliance impact:
- EDC CRF submission endpoints
- Safety integration endpoints
- Regulatory document submission gateways
Standard priority — operational efficiency:
- CTMS management endpoints
- Report generation APIs
- Support and query management endpoints
Step 2: Configure Heartbeat Monitors for Data Sync Jobs
Clinical trial platforms run critical batch jobs outside business hours:
- Nightly EDC data extract to data management systems
- Daily ePRO sync from patient devices
- Automated safety reconciliation between EDC and PV system
- Scheduled regulatory archive jobs
Add a Vigilmon heartbeat for each job. If a job fails or doesn't complete within its expected window, Vigilmon alerts immediately.
Step 3: Set Up a Clinical Operations Status Page
When clinical systems are degraded, site coordinators need immediate status visibility without routing through IT helpdesk queues. Configure a Vigilmon status page with groups for:
- EDC availability
- RTSM / randomisation service
- ePRO patient application
- Safety reporting systems
Publish the status page URL in your site manual and investigator site files so coordinators can self-check during business hours.
Step 4: Configure Escalation Routing by Clinical Severity
- RTSM randomisation down: Immediate alert to clinical operations director + IT on-call; invoke paper backup procedure
- EDC unavailable 15+ minutes: Clinical operations manager + data management lead + site coordinator notification
- ePRO sync failure: Data management team alert within expected sync window
- Safety integration failure: Immediate pharmacovigilance and clinical operations alert
- SSL certificate expiry under 30 days: Validated change control initiated; infrastructure team weekly digest
Step 5: Monitor External Partner and CRO Integrations
Large trials often involve multiple CROs, central labs, imaging vendors, and ePRO vendors — each operating independent systems. Add monitors for the integration endpoints between your core systems and each partner. Integration failures between a central lab's results system and the EDC are common sources of data discrepancies that only surface during data cleaning — catching them at the API level reduces the manual reconciliation burden.
Getting Started
Clinical trial tech platforms carry a monitoring obligation that goes beyond commercial SLA management. When data capture, randomisation, and safety reporting systems fail undetected, the consequences are measured in protocol deviations, missing data, and regulatory risk — not just engineering downtime metrics.
Vigilmon gives your clinical IT and operations teams the visibility to detect platform failures before they affect site operations, patient data completeness, or regulatory reporting obligations.
Start monitoring your clinical trial platform at vigilmon.online — free for up to five monitors, one-minute check intervals, Slack alerts, and a status page included. No credit card required.
Tags: #clinicaltrials #healthtech #EDC #ePRO #RTSM #GCP #uptime #monitoring #pharma